✦ LIBER ✦

Towards more “informed” consent in clinical trials: An information booklet for patients and physicians in the UK

✍ Scribed by Philippa Easterbrook; Joan Houghton; Mike Baum

Book ID: 113297315
Publisher: Elsevier Science
Year: 1991
Tongue: English
Weight: 87 KB
Volume: 12
Category: Article
ISSN: 0197-2456
DOI: 10.1016/0197-2456(91)90173-j

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Breast Cancer Patients’ Attitudes Toward

Breast Cancer Patients’ Attitudes Toward Clinical Trials in the Radiation Oncology Clinic Versus Those Searching for Trial Information on the Internet

✍ Christopher M. Dolinsky; S. Jack Wei; Margaret K. Hampshire; James M. Metz 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB

Informed consent and patient participati

Informed consent and patient participation in the medical encounter: a list of questions for an informed choice about the type of anaesthesia

✍ E. Paci; M. G. Barneschi; G. Miccinesi; S. Falchi; L. Metrangolo; G. P. Novelli 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 49 KB

Are Two Drugs Better Than One For Acute

Are Two Drugs Better Than One For Acute Agitation? A Discussion On Black Box Warnings, Waiver of Informed Consent, and the Ethics of Enrolling Impaired Subjects in Clinical Trials

✍ Stephanie A. Eucker; Tyler W. Barrett; David L. Schriger 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 379 KB

B cell depletion may be more effective t

B cell depletion may be more effective than switching to an alternative anti–tumor necrosis factor agent in rheumatoid arthritis patients with inadequate response to anti–tumor necrosis factor agents

✍ Axel Finckh; Adrian Ciurea; Laure Brulhart; Diego Kyburz; Burkhard Möller; Silvi 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB 👁 2 views

## Abstract ## Objective Patients with rheumatoid arthritis (RA) in whom the response to anti–tumor necrosis factor (anti‐TNF) therapy is inadequate have several therapeutic options, such as switching to an alternative anti‐TNF agent or initiating B cell–depleting therapy with rituximab (RTX). Alt

MAGNA CARTAThe Great CharterPreamble

📂 Fiction 🌐 English ⚖ 11 KB 👁 18 views